` Comparison: SUPN vs LLY - Alpha Spread

SUPN
vs
LLY

Over the past 12 months, SUPN has significantly outperformed LLY, delivering a return of +49% compared to the LLY's +6% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
SUPN
LLY
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

SUPN Intrinsic Value
HIDDEN
Show
LLY Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
49.38 USD
Eli Lilly and Co
NYSE:LLY
903.02 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
SUPN, LLY

SUPN
LLY
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Supernus Pharmaceuticals Inc
Revenue
Eli Lilly and Co
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
SUPN, LLY

SUPN
LLY
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Eli Lilly and Co
NYSE:LLY
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

SUPN
89.9%
LLY
83%

Operating Margin

SUPN
1.7%
LLY
45.6%

Net Margin

SUPN
-5.4%
LLY
31.7%

FCF Margin

SUPN
6.4%
LLY
9.2%

ROE

SUPN
-3.7%
LLY
101.4%

ROA

SUPN
-2.7%
LLY
21.6%

ROIC

SUPN
1%
LLY
27.7%

ROCE

SUPN
1.1%
LLY
46.6%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
SUPN, LLY

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SUPN, LLY

Performance Gap Between SUPN and LLY
HIDDEN
Show

Performance By Year
SUPN, LLY

Loading
SUPN
LLY
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare SUPN to other stocks
EPE
Epizyme Inc
E
More expensive
vs SUPN
JNJ
Johnson & Johnson
More expensive
vs SUPN
ROG
Roche Holding AG
Cheaper
vs SUPN
AZN
AstraZeneca PLC
More expensive
vs SUPN
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett